[Antiretroviral therapy in 2004].
Since its inception, highly active antiretroviral therapy (HAART) has undergone constant further development. The German Aids Society (DIG), but also the British HIV Association (BHIVA) and the North American Department of Health and Human Services (DHHS) have all issued recommendations on HAART. A comparison of these recommendations reveals that despite the many points they have in common, gaps in our knowledge, and shortcomings in both the diagnosis and treatment of HIV infections still persist.
Jablonowski
H
H
Medizinischen Klinik, Klinikum Salzgitter GmbH.
D019380:Anti-HIV Agents / Q000009:adverse effects / Q000627:therapeutic use*; D044966:Anti-Retroviral Agents / Q000009:adverse effects / Q000627:therapeutic use*; D023241:Antiretroviral Therapy, Highly Active / Q000639:trends*; D018791:CD4 Lymphocyte Count; D003431:Cross-Cultural Comparison; D019317:Evidence-Based Medicine; D005544:Forecasting; D015658:HIV Infections / Q000188:drug therapy* / Q000821:virology; D015497:HIV-1 / Q000187:drug effects*; D006801:Humans; D017410:Practice Guidelines as Topic; D012955:Societies, Medical; D019562:Viral Load
D019380:Anti-HIV Agents; D044966:Anti-Retroviral Agents
Empfehlungen zur antiretroviralen Therapie im internationalen Vergleich. Welche ART ist "up to date"?